Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) was the recipient of a large drop in short interest during the month of March. As of March 13th, there was short interest totaling 3,511 shares, a drop of 19.0% from the February 26th total of 4,337 shares. Based on an average daily volume of 21,842 shares, the short-interest ratio is currently 0.2 days.
Alpha Tau Medical Price Performance
Alpha Tau Medical stock traded down $0.01 during trading hours on Wednesday, hitting $0.99. 15,160 shares of the stock were exchanged, compared to its average volume of 47,162. The business’s 50-day moving average is $1.04 and its two-hundred day moving average is $0.61. Alpha Tau Medical has a 12 month low of $0.13 and a 12 month high of $1.50.
About Alpha Tau Medical
Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.
The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.
Read More
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
